Extended-spectrum beta-lactamases: the end of cephalosporins?

Isr Med Assoc J. 2005 May;7(5):336-8.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Bacteria / drug effects*
  • Cephalosporin Resistance / physiology*
  • Cephalosporins* / pharmacology
  • Humans
  • Israel
  • Risk Factors
  • beta-Lactamases* / biosynthesis
  • beta-Lactamases* / drug effects

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • beta-Lactamases